New hope for Tough-to-Treat pancreatic cancer?
NCT ID NCT04896073
Summary
This study tested an oral drug called Minnelide for adults with a rare and aggressive form of pancreatic cancer (adenosquamous carcinoma) that had stopped responding to prior treatments. The goal was to see if the drug could control the cancer's growth. Participants took the drug daily in repeating cycles for up to a year while doctors monitored their response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOSQUAMOUS CARCINOMA OF THE PANCREAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.